Hutchin Hill Capital, LP - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 197 filers reported holding HAEMONETICS CORP in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Hutchin Hill Capital, LP ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q4 2017$465,000
-61.6%
8,000
-70.4%
0.13%
+182.6%
Q3 2017$1,211,000
-68.2%
27,000
-71.3%
0.05%
-55.8%
Q1 2017$3,814,000
+113.2%
94,000
+111.2%
0.10%
+67.7%
Q4 2016$1,789,000
+180.4%
44,500
+178.1%
0.06%
+6.9%
Q3 2013$638,00016,0000.06%
Other shareholders
HAEMONETICS CORP shareholders Q4 2016
NameSharesValueWeighting ↓
BEACONLIGHT CAPITAL, LLC 95,033$8,511,0002.84%
Advantage Alpha Capital Partners LP 100,170$8,971,0002.10%
Nitorum Capital, L.P. 395,635$35,433,0001.82%
Summit Creek Advisors LLC 127,600$11,428,0001.68%
Bridge City Capital, LLC 40,559$3,632,0001.67%
AEGON ASSET MANAGEMENT UK PLC 520,408$46,603,0001.05%
Jackson Square Partners, LLC 2,298,190$205,825,0001.03%
Parkman Healthcare Partners LLC 30,147$2,700,0000.76%
TEALWOOD ASSET MANAGEMENT INC 9,154$820,0000.54%
AMERICAN CAPITAL MANAGEMENT INC 159,145$14,253,0000.52%
View complete list of HAEMONETICS CORP shareholders